|
BQS-Bundesauswertung
2006 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Aortenklappenchirurgie,
isoliert |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Übersicht Qualitätsindikatoren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Übersicht Qualitätsindikatoren |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälle Gesamt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl isolierter Operationen an der
Aortenklappe |
|
|
|
|
|
|
|
|
|
|
|
|
11.045 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Anzahl Patienten, die in ihrer ersten
Operation isoliert |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
an der Aortenklappe operiert wurden |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.994 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ergebnis |
|
|
Ergebnis |
|
Referenz- |
|
|
|
|
|
Qualitätsindikator |
|
|
|
|
|
|
|
|
|
|
Anzahl |
|
|
|
% |
|
|
bereich |
|
Seite |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 1: Postoperative Mediastinitis |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit elektiver oder |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
dringlicher Operationsindikation ohne |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
präoperative Mediastinitis bzw. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Wundinfektion des Thorax |
|
|
|
|
|
|
89 / 10.541 |
|
|
0,84% |
|
nicht definiert |
|
|
1.1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit Risikoklasse 0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
oder Risikoklasse 1 |
|
|
|
|
|
|
|
|
60 / 8.742 |
|
|
0,69% |
|
|
<= 3,2% |
|
|
1.4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 2: Postoperative |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Retentionsstörung |
|
|
|
|
|
|
|
|
347 / 9.181 |
|
|
3,78% |
|
|
<= 7% |
|
|
1.7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 3: Neurologische Komplikationen |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten ohne neurologische |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vorerkrankungen und Dauer des |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
zerebrovaskulären Ereignisses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
zwischen > 24 h bis <= 72 h |
|
|
|
|
|
|
50 / 9.974 |
|
|
0,50% |
|
nicht definiert |
|
1.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten ohne neurologische |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vorerkrankungen und Dauer des |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
zerebrovaskulären Ereignisses > 72 h |
|
|
|
|
138 / 9.974 |
|
|
1,38% |
|
|
<= 4,9% |
|
1.10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
QI 4: Letalität |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-Hospital-Letalität bei allen Patienten, |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
die in ihrer ersten Operation isoliert an |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
der Aortenklappe operiert wurden |
|
|
|
|
|
422 / 10.994 |
|
|
3,84% |
|
nicht definiert |
|
1.14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-Hospital-Letalität bei Patienten mit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
elektiver oder dringlicher Operations- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
indikation |
|
|
|
|
|
|
|
|
|
|
337 / 10.555 |
|
|
3,19% |
|
|
<= 8,1% |
|
1.14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
In-Hospital-Letalität bei Patienten mit |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Notfall- oder Notfall (Reanimation/ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ultima ratio)-Operationen |
|
|
|
|
|
|
|
|
85 / 439 |
|
|
19,36% |
|
nicht definiert |
|
1.14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30-Tage-Letalität: Follow-up-Rate |
|
|
|
|
8.321 / 10.994 |
|
|
75,69% |
|
nicht definiert |
|
1.18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30-Tage-Letalität in Krankenhäusern |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
mit einer Follow-up-Rate >= 97% |
|
|
|
|
|
229 / 5.815 |
|
|
3,94% |
|
nicht definiert |
|
1.19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30-Tage-Letalität in Krankenhäusern |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
mit einer Follow-up-Rate >= 97% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bei Patienten mit vollständiger |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Dokumentation zum EuroSCORE |
|
|
|
|
|
218 / 5.688 |
|
|
3,83% |
|
nicht definiert |
|
1.21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
© BQS 2007 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
01.06.2007 / 2006 - D4898-L39644-P19794 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
